McCarthy Asset Management
TTRX icon

McCarthy Asset Management’s Turn Therapeutics TTRX Stock Holding History

McCarthy Asset Management’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$216K Hold
15,018
– – 0.1% 27
2026
Q2 		$110K Buy
+15,018
New +$69.8K 0.05% 29

Other funds holding TTRX

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $508M AUM 11.76% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

McCarthy Asset Management's TTRX Position: Q3 2026 in Review

McCarthy Asset Management held its Turn Therapeutics (TTRX) position steady in Q3 2026 at 15,018 shares worth $216K. The position accounts for 0.1% of the portfolio, ranked #27.

McCarthy Asset Management first reported a position in TTRX in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

  • McCarthy Asset Management held 15,018 shares of Turn Therapeutics worth $216K as of Q3 2026.
  • McCarthy Asset Management left its Turn Therapeutics share count unchanged in Q3 2026.
  • Turn Therapeutics made up 0.1% of McCarthy Asset Management's portfolio in Q3 2026, its #27 holding.
  • McCarthy Asset Management first reported a position in Turn Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 7 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on McCarthy Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.